References
- Bae Y, Jang WD, Nishiyama N, et al. (2005a). Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol Biosys 1:242–50
- Bae Y, Nishiyama N, Fukushima S, et al. (2005b). Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 16:122–30
- Chen D, Jiang X, Liu J, et al. (2010a). In vivo evaluation of novel pH-sensitive mPEG-Hz-Chol conjugate in liposomes: pharmacokinetics, tissue distribution, efficacy assessment. Artif Cells Blood Substit Immobil Biotechnol 38:136–42
- Chen D, Jiang X, Huang Y, et al. (2010b). pH-Sensitive mPEG-Hz-cholesterol conjugates as a liposome delivery system. J Bioact Compat Polym 25:527–42
- Chen D, Liu W, Shen Y, et al. (2011). Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon. Int J Nanomedicine 6:2053–61
- Chen D, Sun K, Mu H, et al. (2012). pH and temperature dual-sensitive liposome gel based on novel cleavable mPEG-Hz-CHEMS polymeric vaginal delivery system. Int J Nanomedicine 7:2621–30
- Chen D, Hong Y, Hong M, et al. (2013). Novel chitosan derivative for temperature and ultrasound dual-sensitive liposomal microbubble gel. Carbohydrate Polymers 94:17–23
- Davis ME, Chen ZG, Shin DM. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–82
- Fiore VF, Lofton MC, Roser-Page S, et al. (2010). Polyketal microparticles for therapeutic delivery to the lung. Biomaterials 31:810–17
- Ganta S, Devalapally H, Shahiwala A, Amiji M. (2008). A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release 126:187–204
- Gelderblom H, Verweij J, Nooter K, Sparreboom A. (2001). Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37:1590–8
- Heller J, Barr J. (2004). Poly(ortho esters)-from concept to reality. Biomacromolecules 5:1625–32
- Heffernan M, Murthy N. (2005). Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle. Bioconjug Chem 16:1340–2
- Hallaj-Nezhadi S, Dass CR, Lotfipour F. (2013). Intraperitoneal delivery of nanoparticles for cancer gene therapy. Future Oncol 9:59–68
- Mo R, Xiao Y, Sun M, et al. (2011a). Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption. Int J Pharm 409:38–45
- Mo R, Jin X, Li N, et al. (2011b). The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 32:4609–20
- Oh KT, Kim D, You HH, et al. (2009). pH-sensitive properties of surface charge-switched multifunctional polymeric micelle. Int J Pharm 376:134–40
- Park JS, Oh YK, Yoon H, et al. (2002). In situ gelling and mucoadhesive polymer vehicles for controlled intranasal delivery of plasmid DNA. J Biomed Mater Res 59:144–51
- Qian WY, Sun DM, Zhu RR, et al. (2012). pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release. Int J Nanomedicine 7:5781–92
- Siepmann J, Göpferich A. (2001). Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev 48:229–47
- Singla AK, Garg A, Aggarwal D. (2002). Paclitaxel and its formulations. Int J Pharm 235:179–92
- Szebeni J, Muggia FM, Alving CR. (1998). Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst 90:300–6
- von Burkersroda F, Schedl L, Göpferich A. (2002). Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials 23:4221–31
- Yuk SH, Oh KS, Koo H, et al. (2011). Multi-core vesicle nanoparticles based on vesicle fusion for delivery of chemotherapic drugs. Biomaterials 32:7924–31
- Zhang JA, Anyarambhatla G, Ma L, et al. (2005). Development and characterization of a novel Cremophor EL free liposome-base paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59:177–87